Alnylam Pharmaceuticals, Inc.

NISA INVESTMENT ADVISORS, LLC ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/15/2026

Shares

9,649

Value ($000)

3,837

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/15/2026	3,837	0.0%	9,649	12/31/2025
2025 Q3	10/23/2025	5,533	0.0%	12,133	9/30/2025
2025 Q2	7/31/2025	2,688	0.0%	8,242	6/30/2025
2025 Q1	4/30/2025	2,202	0.0%	8,155	3/31/2025
2024 Q4	1/17/2025	3,134	0.0%	13,317	12/31/2024
2024 Q3	10/24/2024	3,171	0.0%	11,528	9/30/2024
2024 Q2	7/19/2024	1,982	0.0%	8,155	6/30/2024
2024 Q1	5/2/2024	1,219	0.0%	8,155	3/31/2024
2023 Q4	1/25/2024	1,561	0.0%	8,155	12/31/2023
2023 Q3	11/2/2023	1,444	0.0%	8,155	9/30/2023
2023 Q2	8/11/2023	1,549	0.0%	8,155	6/30/2023
2023 Q1	5/2/2023	2,074	0.0%	10,355	3/31/2023
2022 Q4	2/2/2023	2,467	0.0%	10,380	12/31/2022
2022 Q3	11/7/2022	2,085	0.0%	10,380	9/30/2022
2022 Q2	8/3/2022	1,565	0.0%	10,733	6/30/2022
2022 Q1	4/29/2022	1,271	0.0%	7,783	3/31/2022
2021 Q4	2/3/2022	1,206	0.0%	8,767	12/31/2021
2021 Q3	10/18/2021	5,764	0.0%	30,527	9/30/2021
2021 Q2	8/6/2021	2,223	0.0%	13,112	6/30/2021
2021 Q1	4/26/2021	4,379	0.0%	31,012	3/31/2021
2020 Q4	1/25/2021	1,990	0.0%	15,312	12/31/2020
2020 Q3	10/20/2020	1,812	0.0%	12,442	9/30/2020
2020 Q2	7/27/2020	2,497	0.0%	16,858	6/30/2020
2020 Q1	4/17/2020	1,358	0.0%	12,480	3/31/2020
2019 Q4	1/17/2020	1,207	0.0%	10,480	12/31/2019